Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Non-Current Assets (2021 - 2025)

Bioadaptives' Non-Current Assets history spans 5 years, with the latest figure at $15500.0 for Q3 2025.

  • For Q3 2025, Non-Current Assets changed N/A year-over-year to $15500.0; the TTM value through Sep 2025 reached $32500.0, down 2.81%, while the annual FY2023 figure was $15441.0, 416.42% up from the prior year.
  • Non-Current Assets for Q3 2025 was $15500.0 at Bioadaptives, down from $17000.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $166625.0 in Q3 2023 and bottomed at $1644.0 in Q2 2023.
  • The 5-year median for Non-Current Assets is $17000.0 (2025), against an average of $38309.1.
  • The largest annual shift saw Non-Current Assets crashed 96.38% in 2022 before it skyrocketed 4435.25% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $59709.0 in 2021, then plummeted by 94.99% to $2990.0 in 2022, then surged by 416.42% to $15441.0 in 2023, then grew by 16.57% to $18000.0 in 2024, then fell by 13.89% to $15500.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Non-Current Assets are $15500.0 (Q3 2025), $17000.0 (Q2 2025), and $18000.0 (Q1 2024).